Last Updated: June 22, 2026

OCTREOTIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Octreotide patents expire, and what generic alternatives are available?

Octreotide is a drug marketed by Fresenius Kabi Usa, Gland, Heritage, Meitheal, Mylan Labs Ltd, Sagent Pharms Inc, Shuangcheng, Sun Pharm Inds, Teva Pharms Usa Inc, West-ward Pharms Int, Wockhardt Usa, and Mylan Institutional. and is included in twenty-three NDAs.

The generic ingredient in OCTREOTIDE is octreotide acetate. There are twenty drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the octreotide acetate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Octreotide

A generic version of OCTREOTIDE was approved as octreotide acetate by WEST-WARD PHARMS INT on April 8th, 2005.

  Start Trial

AI Deep Research
Ask!
Questions you can ask:
  • What is the 5 year forecast for OCTREOTIDE?
  • What are the global sales for OCTREOTIDE?
  • What is Average Wholesale Price for OCTREOTIDE?
Summary for OCTREOTIDE
US Patents:0
Applicants:12
NDAs:23
Drug Prices: Drug price information for OCTREOTIDE
DailyMed Link:OCTREOTIDE at DailyMed
Drug patent expirations by year for OCTREOTIDE
Drug Prices for OCTREOTIDE

See drug prices for OCTREOTIDE

US Patents and Regulatory Information for OCTREOTIDE

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa OCTREOTIDE ACETATE (PRESERVATIVE FREE) octreotide acetate INJECTABLE;INJECTION 077457-002 Feb 10, 2006 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sun Pharm Inds OCTREOTIDE ACETATE octreotide acetate INJECTABLE;INJECTION 077373-002 Aug 14, 2007 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
West-ward Pharms Int OCTREOTIDE ACETATE (PRESERVATIVE FREE) octreotide acetate INJECTABLE;INJECTION 076313-001 Mar 28, 2005 AP RX No Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Mylan Institutional OCTREOTIDE ACETATE (PRESERVATIVE FREE) octreotide acetate INJECTABLE;INJECTION 079198-003 Feb 10, 2011 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
West-ward Pharms Int OCTREOTIDE ACETATE (PRESERVATIVE FREE) octreotide acetate INJECTABLE;INJECTION 076313-003 Mar 28, 2005 AP RX No Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

DrugChatter Q&A for OCTREOTIDE
Octreotide 30 mg injection price?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links